| Date Filed | Type | Description |
| 06/07/2023 |
4
| Hillan Kenneth J. (Chief Therapeutics Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Granted 44,381 shares
@ $0
Paid exercise price by delivering 15,347 shares
@ $2.08, valued at
$31.9k
|
|
| 06/05/2023 |
4
| Hillan Kenneth J. (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 13,900 shares
@ $0
Granted 27,750 options to buy
@ $1.11, valued at
$30.8k
|
|
| 05/23/2023 |
4
| Hillan Kenneth J. (Chief Therapeutics Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Paid exercise price by delivering 4,628 shares
@ $1.94, valued at
$9k
|
|
| 02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2022 |
4
| Hillan Kenneth J. (Chief Therapeutics Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Paid exercise price by delivering 4,628 shares
@ $2.99, valued at
$13.8k
|
|
| 08/25/2022 |
4
| Hillan Kenneth J. (Chief Therapeutics Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Sold 8,753 shares
@ $3.64, valued at
$31.9k
|
|
| 08/22/2022 |
4
| Hillan Kenneth J. (Chief Therapeutics Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Paid exercise price by delivering 4,628 shares
@ $3.33, valued at
$15.4k
|
|
| 06/02/2022 |
4
| Hillan Kenneth J. (Chief Therapeutics Officer) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Paid exercise price by delivering 4,627 shares
@ $2.82, valued at
$13k
|
|
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4
| Hillan Kenneth J. (Head of Therapeutics) has filed a Form 4 on 23andMe Holding Co.|
Txns:
| Granted 214,091 shares
@ $0
Granted 471,413 options to buy
@ $5, valued at
$2.4M
|
|
| 06/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/11/2020 |
4
| Hillan Kenneth J. (Director) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 15,000 shares
@ $0
Granted 30,000 options to buy
@ $10.43, valued at
$312.9k
|
|
| 09/11/2020 |
3
| Hillan Kenneth J. (Director) has filed a Form 3 on SANGAMO THERAPEUTICS, INC |
| 05/12/2020 |
4
| Hillan Kenneth J. (Director) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 9,000 options to buy
@ $35.49, valued at
$319.4k
|
|
| 05/08/2019 |
4
| Hillan Kenneth J. (Director) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 10,000 options to buy
@ $19.11, valued at
$191.1k
|
|
| 01/02/2019 |
3
| Hillan Kenneth J. (Director) has filed a Form 3 on Zymeworks Inc. |
| 06/29/2018 |
4
| Hillan Kenneth J. (See Remarks) has filed a Form 4 on Achaogen Inc|
Txns:
| Exercised 132,727 options to buy
@ $6.93, valued at
$919.8k
Exercised 45,208 options to buy
@ $3.65, valued at
$165k
|
|
| 06/28/2018 |
4
| Hillan Kenneth J. (See Remarks) has filed a Form 4 on Achaogen Inc|
Txns:
| Granted 2,150 shares
@ $0
Sold 744 shares
@ $9.59, valued at
$7.1k
Granted 10,000 options to buy
@ $10.64, valued at
$106.4k
|
|
| 05/15/2018 |
4
| Hillan Kenneth J. (See Remarks) has filed a Form 4 on Achaogen Inc|
Txns:
| Granted 17,100 shares
@ $0
Granted 80,000 options to buy
@ $10.64, valued at
$851.2k
|
|
| 03/15/2018 |
4
| Hillan Kenneth J. (See Remarks) has filed a Form 4 on Achaogen Inc|
Txns:
| Sold 2,735 shares
@ $11.74, valued at
$32.1k
|
|
| 02/23/2018 |
4
| Hillan Kenneth J. (See Remarks) has filed a Form 4 on Achaogen Inc|
Txns:
| Sold 4,606 shares
@ $10.67, valued at
$49.1k
|
|
| 03/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/02/2016 |
4
| Hillan Kenneth J. (Director) has filed a Form 4 on Relypsa Inc|
Txns:
| Unknown transaction of 1,237 shares
@ $32, valued at
$39.6k
Disposed/sold 2,250 shares
@ $32, valued at
$72k
Disposed/sold 12,000 options to buy
@ $23.96, valued at
$287.5k
Disposed/sold 4,500 options to buy
@ $35.79, valued at
$161.1k
Disposed/sold 4,500 options to buy
@ $17, valued at
$76.5k
|
|
| 06/23/2016 |
4
| Hillan Kenneth J. (Director) has filed a Form 4 on Relypsa Inc|
Txns:
| Granted 2,250 shares
@ $0
Granted 4,500 options to buy
@ $17, valued at
$76.5k
|
|
| 06/08/2016 |
4
| Hillan Kenneth J. (Director) has filed a Form 4 on Relypsa Inc|
Txns:
| Sold 1,013 shares
@ $19.3115, valued at
$19.6k
|
|
| 03/21/2016 |
4
| Hillan Kenneth J. (CEO) has filed a Form 4 on Achaogen Inc|
Txns:
| Sold 3,572 shares
@ $3.22, valued at
$11.5k
|
|